CPHI vs GRMN · rev $4.1M vs P/E 28, rev $6.30B
China Pharma Holdings Inc (CPHI) versus Garmin Ltd (GRMN) — a side-by-side from cached financials, not a winner call.
China Pharma Holdings Inc (CPHI) is a drug manufacturers - specialty & generic company listed on US.
Garmin Ltd (GRMN) is a scientific & technical instruments company listed on US.
Latest reported CPHI revenue for 2025-12-31 was $4.1M. Net income was -$3.2M. Revenue was down 8.5% from 2024-12-31 to 2025-12-31. CPHI currently screens at market cap $29.0M.
Latest reported GRMN revenue for 2024-12-28 was $6.30B. Net income was $1.41B. Revenue was up 20.4% from 2023-12-30 to 2024-12-28. GRMN currently screens at market cap $41.35B and trailing P/E 28.3.
CPHI currently screens at market cap $29.0M. GRMN currently screens at market cap $41.35B and trailing P/E 28.3.
Not investment advice. Open the CPHI and GRMN stock pages for the full models.
Not investment advice.